Epistatic Features and Machine Learning Improve Alzheimer's Risk Prediction Over Polygenic Risk Scores
Hermes, S.; Cady, J.; Armentrout, S.; O'Connor, J.; Carlson, S.; Cruchaga, C.; Wingo, T.; Greytak, E. M.; The Alzheimer's Disease Neuroimaging Initiative,
Show abstract
BackgroundPolygenic risk scores (PRS) are linear combinations of genetic markers weighted by effect size that are commonly used to predict disease risk. For complex heritable diseases such as late onset Alzheimers disease (LOAD), PRS models fail to capture much of the heritability. Additionally, PRS models are highly dependent on the population structure of data on which effect sizes are assessed, and have poor generalizability to new data. ObjectiveThe goal of this study is to construct a paragenic risk score that, in addition to single genetic marker data used in PRS, incorporates epistatic interaction features and machine learning methods to predict lifetime risk for LOAD. MethodsWe construct a new state-of-the-art genetic model for lifetime risk of Alzheimers disease. Our approach innovates over PRS models in two ways: First, by directly incorporating epistatic interactions between SNP loci using an evolutionary algorithm guided by shared pathway information; and second, by estimating risk via an ensemble of machine learning models (gradient boosting machines and deep learning) instead of simple logistic regression. We compare the paragenic model to a PRS model from the literature trained on the same dataset. ResultsThe paragenic model is significantly more accurate than the PRS model under 10-fold cross-validation, obtaining an AUC of 83% and near-clinically significant matched sensitivity/specificity of 75%, and remains significantly more accurate when evaluated on an independent holdout dataset. Additionally, the paragenic model maintains accuracy within APOE genotypes. ConclusionParagenic models show potential for improving lifetime disease risk prediction for complex heritable diseases such as LOAD over PRS models.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Effect of Pathway-specific Polygenic Risk Scores for Alzheimer’s Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals 94%
- Screening for early-stage Alzheimer's disease using optimized feature sets and machine learning 94%
- Alzheimer’s Disease variant portal (ADVP): a catalog of genetic findings for Alzheimer’s Disease 94%
Similar papers in this journal
- An X Chromosome Transcriptome Wide Association Study Implicates ARMCX6 in Alzheimer's Disease 96%
- Brain and Blood Transcriptome-Wide Association Studies Identify Five Novel Genes Associated with Alzheimer’s Disease 95%
- Quantitative longitudinal predictions of Alzheimer's disease by multi-modal predictive learning 94%
Similar papers in this journal
- c-Triadem: A constrained, explainable deep learning model to identify novel biomarkers in Alzheimer’s disease 96%
- Assessing the performance of genome-wide association studies for predicting disease risk 94%
- Identification of functionally connected multi-omic biomarkers for Alzheimer’s Disease using modularity-constrained Lasso 93%